References
- Rosenfeld JV, Maas AI, Bragge P, et al. Early management of severe traumatic brain injury. Lancet 2012;380:1088–98
- Hawkins BT, Davis TP. The blood–brain barrier/neurovascular unit in health and disease. Pharmacol Rev 2005;57:173–85
- Werner C, Engelhard K. Pathophysiology of traumatic brain injury. Br J Anaesth 2007;99:4–9
- Kitagawa K, Matsumoto M, Tagaya M, et al. Temporal profile of serum albumin extravasation following cerebral ischemia in a newly established reproducible gerbil model for vasogenic brain edema: a combined immunohistochemical and dye tracer analysis. Acta Neuropathol 1991;82:164–71
- Sashindranath M, Sales E, Daglas M, et al. The tissue-type plasminogen activator-plasminogen activator inhibitor 1 complex promotes neurovascular injury in brain trauma: evidence from mice and humans. Brain 2012;135:3251–64
- Unterberg AW, Stover J, Kress B, Kiening KL. Edema and brain trauma. Neuroscience 2004;129:1019–27
- Shlosberg D, Benifla M, Kaufer D, Friedman A. Blood–brain barrier breakdown as a therapeutic target in traumatic brain injury. Nat Rev Neurol 2010;6:393–403
- Mori T, Wang XY, Kline AE, et al. Reduced cortical injury and edema in tissue plasminogen activator knockout mice after brain trauma. Neuroreport 2001;12:4117–20
- Sashindranath M, Samson AL, Downes CE, et al. Compartment- and context-specific changes in tissue-type plasminogen activator (tPA) activity following brain injury and pharmacological stimulation. Lab Investig 2011;91:1079–91
- Matsumura Y, Maeda H. A new concept for macromolecular therapeutics in cancer-chemotherapy – mechanism of tumoritropic accumulation of proteins and the antitumor agent smancs. Cancer Res 1986;46:6387–92
- Caraglia M, Marra M, Misso G, et al. Tumour-specific uptake of anti-cancer drugs: the future is here. Curr Drug Metab 2012;13:4–21
- Kaminskas LM, McLeod VM, Porter CJH, Boyd BJ. Differences in colloidal structure of PEGylated nanomaterials dictate the likelihood of accelerated blood clearance. J Pharm Sci 2011;100:5069–77
- Boyd BJ, Kaminskas LM, Karellas P, et al. Cationic poly-l-lysine dendrimers: pharmacokinetics, biodistribution, and evidence for metabolism and bioresorption after intravenous administration to rats. Mol Pharm 2006;3:614–27
- Kaminskas LM, McLeod VM, Kelly BD, et al. A comparison of changes to doxorubicin pharmacokinetics, antitumor activity, and toxicity mediated by PEGylated dendrimer and PEGylated liposome drug delivery systems. Nanomed Nanotechnol Biol Med 2012;8:103–11
- Kiselev MA, Gryzunov Iu A, Dobretsov GE, Komarova MN. Size of a human serum albumin molecule in solution. Biofizika 2001;46:423–7
- Rashid H, Muzammil S, Tayyab S. Comparison of bilirubin binding and other molecular properties of tile serum albumin of several mammalian species. IUBMB Life 1998;44:165–73
- Kaminskas LM, Boyd BJ, Karellas P, et al. The impact of molecular weight and PEG chain length on the systemic pharmacokinetics of PEGylated poly l-lysine dendrimers. Mol Pharm 2008;5:449–63
- Takanashi Y, Ishida T, Kirchmeier MJ, et al. Neuroprotection by intrathecal application of liposome-entrapped fasudil in a rat model of ischemia. Neurol Med-Chir 2001;41:107–13
- Allen TM, Hansen CB, Guo LS. Subcutaneous administration of liposomes: a comparison with the intravenous and intraperitoneal routes of injection. Biochim Biophys Acta 1993;1150:9–16
- Gillies ER, Dy E, Frechet JM, Szoka FC. Biological evaluation of polyester dendrimer: poly(ethylene oxide) “bow-tie” hybrids with tunable molecular weight and architecture. Mol Pharm 2005;2:129–38
- Kaminskas LM, Kelly BD, McLeod VM, et al. Pharmacokinetics and tumor disposition of PEGylated, methotrexate conjugated poly-l-lysine dendrimers. Mol Pharm 2009;6:1190–204
- Lee CC, Gillies ER, Fox ME, et al. A single dose of doxorubicin-functionalized bow-tie dendrimer cures mice bearing C-26 colon carcinomas. Proc Natl Acad Sci USA 2006;103:16649–54
- Ishida T, Takanashi Y, Doi H, et al. Encapsulation of an antivasospastic drug, fasudil, into liposomes, and in vitro stability of the fasudil-loaded liposomes. Int J Pharm 2002;232:59–67
- Xiao G, Gan L-S. Receptor-mediated endocytosis and brain delivery of therapeutic biologics. Int J Cell Biol 2013;2013:1–14
- Liddelow SA, Dziegielewska KM, Mollgard K, et al. Cellular specificity of the blood–CSF barrier for albumin transfer across the choroid plexus epithelium. PLoS One 2014;9
- Thorne RG, Nicholson C. In vivo diffusion analysis with quantum dots and dextrans predicts the width of brain extracellular space. Proc Natl Acad Sci USA 2006;103:5567–72